Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease where invasive
pulmonary myofibroblasts secrete collagen and destroy lung integrity. Here, we show that …
pulmonary myofibroblasts secrete collagen and destroy lung integrity. Here, we show that …
[PDF][PDF] IL-11 is a therapeutic target in idiopathic pulmonary fibrosis
B Ng, J Dong, S Viswanathan, G D'Agostino… - researchgate.net
Idiopathic pulmonary fibrosis (IPF) remains a progressive disease despite best medical
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
B Ng, J Dong, G D'Agostino… - Science …, 2019 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease where invasive
pulmonary myofibroblasts secrete collagen and destroy lung integrity. Here, we show that …
pulmonary myofibroblasts secrete collagen and destroy lung integrity. Here, we show that …
IL-11 Is a Therapeutic Target in Idiopathic Pulmonary Fibrosis
B Ng, J Dong, S Viswanathan… - … CONCEPTS IN LUNG …, 2019 - atsjournals.org
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease defined by invasive
pulmonary myofibroblasts that secrete collagen and destroy lung integrity. Aging, genetic …
pulmonary myofibroblasts that secrete collagen and destroy lung integrity. Aging, genetic …
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis.
B Ng, J Dong, G D'Agostino… - Science …, 2019 - search.ebscohost.com
Targeting IL-11 in lung fibrosis: In idiopathic pulmonary fibrosis (IPF), chronic activation of
invasive fibroblasts is responsible for fibrotic scar formation in the lungs. Patients with IPF …
invasive fibroblasts is responsible for fibrotic scar formation in the lungs. Patients with IPF …
[PDF][PDF] IL-11 is a therapeutic target in idiopathic pulmonary fibrosis
B Ng, J Dong, S Viswanathan, G D'Agostino… - scholar.archive.org
Idiopathic pulmonary fibrosis (IPF) remains a progressive disease despite best medical
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …
IL-11 is a therapeutic target in idiopathic pulmonary fibrosis
B Ng, J Dong, S Viswanathan, G D'Agostino… - bioRxiv, 2018 - biorxiv.org
Idiopathic pulmonary fibrosis (IPF) remains a progressive disease despite best medical
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …
[引用][C] Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
B Ng, J Dong, G D'Agostino, S Viswanathan… - Science Translational …, 2019 - cir.nii.ac.jp
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis.
B Ng, J Dong, G D'Agostino, S Viswanathan… - Science Translational …, 2019 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease where invasive
pulmonary myofibroblasts secrete collagen and destroy lung integrity. Here, we show that …
pulmonary myofibroblasts secrete collagen and destroy lung integrity. Here, we show that …
IL-11 is a therapeutic target in idiopathic pulmonary fibrosis
B Ng, J Dong, S Viswanathan, G D'Agostino… - 2018 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) remains a progressive disease despite best medical
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …
management. We previously identified IL-11 as a critical factor for cardiovascular fibrosis …